Floatz logo

NPC-12G

Tuberous Sclerosis

NobelpharmaUNKNOWNPhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Tuberous Sclerosis cohort.

Asset / SponsorPhaseRating
Everolimus
Hospices Civils de Lyon
Phase 3BBB
Sirolimus
Katarzyna Kotulska
Phase 3BBB
Ganaxolone
Marinus Pharmaceuticals
Phase 3BB
NEUROTOP
GRIN Therapeutics, Inc.
Phase 3BB
Npc-12Y Gel
Nobelpharma
Phase 3BB

View all 21 →

Same molecule, other indications

NPC-12G is also rated in:

atherosclerosisDormant
NR
Indicative · Phase 3
/ 100
View asset →
hypopigmentation of the skinDormant
NR
Indicative · Phase 3
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →